{
Novartis AG

Companies

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-03-272025-03-272025-03-312025-03-31115118866442200
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-03-272025-03-272025-03-312025-03-3142218866442200
Download SVG
Download PNG
Download CSV

Swiss stock market opens higher amid improving US and European sentiment

The Swiss stock market opened higher on Thursday, continuing its positive trend from the previous day, buoyed by favorable US data and easing trade tensions. The SMI rose 0.19% to 12,604.86 points, with UBS leading gains at +1.6%, while Nestlé and Roche weighed on the indices. The unemployment rate in Switzerland surpassed 3% in January, reflecting a 20% increase compared to the previous year.
agefi.com
United States Dollar Straumann Holding AG Swiss Prime Site AG Givaudan SA RICHEMONT, Intellectual Property Services Hoffmann-La Roche AG Novartis AG Swiss Re AG Nestlé S.A. Kuehne + Nagel International AG CHE Ipek Ozkardeskaya Philip Jefferson Show more
Finance & Economy, Market Report
09:44 06.02.2025

swiss equities decline as UBS shares slump amid financial market uncertainty

Swiss equities faced a downturn, with the SMI index dropping 0.57% to 12,475.49 points, primarily due to a 7.1% decline in UBS shares amid capital concerns despite positive results. The market remains volatile, influenced by ongoing tariff disputes, particularly with China. Notable losers included Swatch (-3.2%) and Sonova (-3.4%), while Medacta stood out with an 11% gain following strong sales figures.
MarketScreener
Swiss Franc Sonova R Logitech International S.A. PolyPeptide Group AG ABB Ltd Galderma Group N Julius Bär Gruppe AG Zurich, Agence générale Christian Meier SA DSV AS Lonza Group AG Medacta Group SA Novartis AG Nestlé S.A. Hoffmann-La Roche AG CHE Francesco Siccardi Show more
Finance & Economy, Market Report
18:16 04.02.2025

swiss stock market declines amid escalating trade war tensions

The Swiss stock market is under pressure due to escalating trade tensions following the US tariffs on imports from China, Canada, and Mexico. The Swiss Market Index (SMI) fell 0.61%, with only six of the thirty leading stocks gaining, while UBS saw a significant drop of 5.8% amid profit-taking. Analysts warn of potential broader customs barriers as China retaliates with its own tariffs and a complaint to the WTO.
agefi.com
Chinese Yuan United States Dollar Straumann Holding AG RICHEMONT, Intellectual Property Services Lonza Group AG Novartis AG Nestlé S.A. Hoffmann-La Roche AG Sandoz Group AG USA DEU MEX CHN CAN John Plassard Ipek Ozkardeskaya Show more
Finance & Economy, Market Report
11:37 04.02.2025

swiss stock market declines amid rising global trade tensions and tariffs

The Swiss stock market opened lower amid rising global protectionism, influenced by new US tariffs on imports from China, Canada, and Mexico. The Swiss Market Index fell 0.85%, with only four of the thirty leading stocks gaining, including Lonza and Novartis. Analysts note that the escalating trade war is affecting Europe as well, highlighting the complexities of international trade relations.
agefi.com
Chinese Yuan United States Dollar Novartis AG Lonza Group AG Sandoz Group AG Zurich Insurance Group AG USA DEU MEX CHN CAN John Plassard Ipek Ozkardeskaya Show more
Finance & Economy, Market Report
10:21 04.02.2025

us tariffs delay boosts markets while oil prices decline amid trade tensions

US President Donald Trump postponed tariffs on imports from Canada and Mexico, leading to a slight recovery in US stock markets, particularly among car manufacturers. Meanwhile, the euro fluctuated against the dollar, and oil prices fell amid concerns over trade wars and OPEC+ production discussions. The Japanese stock market also rose, benefiting from the tariff suspension.
cash.ch
Swiss Franc Euro United States Dollar Chinese Yuan Japanese Yen Novartis AG Hoffmann-La Roche AG USA MEX JPN CHN CAN Ralf Umlauf Justin Trudeau Susannah Streeter Donald Trump Eugene Leow Show more
Finance & Economy, Market Report
06:25 04.02.2025

Swiss stock market declines as UBS and Sonova shares fall sharply

The Swiss stock market faced a downturn, with the SMI index dropping below 12,500, primarily due to a significant decline in UBS shares amid capital concerns. While some companies like Lonza and Medacta saw gains, others, including Swatch and Sonova, struggled as uncertainty from international tariff disputes continued to weigh on investor sentiment.
Finanz und Wirtschaft
Swiss Franc Sonova R Logitech International S.A. PolyPeptide Group AG Novartis AG Galderma Group N ABB Ltd Julius Bär Gruppe AG Zurich, Agence générale Christian Meier SA Lonza Group AG Medacta Group SA The Swatch Group AG Nestlé S.A. Hoffmann-La Roche AG CHE Francesco Siccardi Show more
Finance & Economy, Market Report
05:52 04.02.2025

global markets decline as trump tariffs raise economic concerns

The Swiss stock market closed lower, with the SMI down 0.40% amid global concerns over Donald Trump's new tariffs on key trading partners, which investors fear could harm the economy. While the services sector in Switzerland showed growth, manufacturing faced significant challenges, leading to workforce cuts. Notable stock movements included Julius Bär dropping 12.7% and Lonza rising 2.7%.
agefi.com
Swiss Franc Euro United States Dollar Chinese Yuan Singapore Dollar Logitech International S.A. Novartis AG ABB Ltd Sika AG RICHEMONT, Intellectual Property Services Lonza Group AG The Swatch Group AG Nestlé S.A. Hoffmann-La Roche AG Sandoz Group AG USA CHN CHE CAN Francisco Ballester John Plassard Peter Stenico Show more
Finance & Economy, Market Report
18:01 03.02.2025

ubs upgrades novartis to buy with target price of 111 francs

UBS has upgraded Novartis to a 'Buy' rating with a target price of 111 Swiss francs, following a review of the company's strong quarterly results. Analyst Matthew Weston has adjusted his estimates accordingly, reflecting confidence in Novartis' performance.
boerse.de
Swiss Franc Novartis AG CHE Matthew Weston Thomas Müller
Finance & Economy, Market Report
12:50 03.02.2025

ubs rates novartis ag as buy with investment risks highlighted

UBS has rated NOVARTIS AG as a 'Buy', but the information provided is for informational purposes only and does not constitute a recommendation to buy or sell. Investing in securities carries risks, including the potential total loss of capital, and expert investment advice is recommended. No liability for the accuracy or completeness of the information is assumed, and the content reflects the views of individual authors rather than wallstreetONLINE.
wallstreetONLINE
Novartis AG CHE
Finance & Economy, Market Report
12:50 03.02.2025

novartis ag sales breakdown and global production footprint overview

Novartis AG is a leading global pharmaceutical company, with sales primarily in oncology (29.9%), immunology (17.2%), and cardiovascular, renal, and metabolic diseases (14.1%). By the end of 2023, it will operate 33 production sites worldwide, with sales distributed across Europe (33%), the USA (39.5%), Asia-Africa-Australasia (20.5%), and Canada and Latin America (7%).
Zonebourse
United States Dollar Novartis AG Show more
Business & Industry, Market Report
12:43 03.02.2025
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Banking Regulations Finance Mergers & Acquisitions Global Financial Events Central Bank Actions Retail and Consumer Goods CEO Changes GDP Growth & Recession Forecasts Global Trade Developments Financial Scams and Security Industry Mergers & Acquisitions Inflation and Monetary Impact Market Analysis and Predictions Government Policies Government Economic Policies Supply Chain Management Startups & Entrepreneurship Domestic Politics
Countries:
USA CHN GBR FRA DEU CHE CAN JPN ITA IND MEX AUS HKG ESP KOR ARE RUS BRA IRL ARG
Companies:
The Goldman Sachs Group, Inc. JPMorgan Chase & Co. Tesla, Inc. Apple Inc. Bank of America Corporation Barclays PLC Wells Fargo & Company Citigroup Inc. Deutsche Bank Money Market PP Morgan Stanley Huawei Technologies CO. Ltd. Lloyds Banking Group plc Microsoft Corporation Credit Suisse Strategic Income I NVIDIA Corporation AXA SA Safran SA Banco Santander, S.A. Novartis AG End Federal Reserve USD
Currencies:
United States Dollar Euro Chinese Yuan British Pound Sterling Swiss Franc Japanese Yen Indian Rupee Russian Ruble Australian Dollar Canadian Dollar United Arab Emirates Dirham Indonesian Rupiah Saudi Riyal South Korean Won Danish Krone Offshore Chinese Yuan Hong Kong Dollar Mexican Peso Malaysian Ringgit Vietnamese Đồng
People:
Donald Trump Elon Musk Goldman Sachs Brad Schimel Troy L Rohrbaugh Sabrina Meng Will Hardcastle Jerome Powell Warren Buffett Robin Leopold Kirsty Roth Klaus Moosmayer Solita Marcelli Bruno Marxer Ulrike Hoffmann-Burchardi Susan P. Crawford Stacey Friedman Joe Biden Sara Wechter Christian Sewing

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.